Abstract
This paper mainly studies the therapeutic effect of azithromycin and hydroxychloroquine on COVID-19. Severe acute respiratory syndrome is one of the key clinical manifestations of COVID-19, and azithromycin is considered to be a feasible treatment. The purpose of this study is to investigate how to use azithromycin to treat COVID-19 better. This article describes the therapeutic effect of azithromycin alone on COVID-19, and the effect of azithromycin and hydroxychloroquine when used in combination with COVID-19. Several studies have shown that although azithromycin has antiviral activity, azithromycin alone has no significant effect on the treatment of COVID-19. In contrast, multiple data show that the combination of azithromycin and hydroxychloroquine has some efficacy in the treatment of COVID-19, and the efficacy is related to the number of days the patient has been ill. The discovery impacts the treatment by providing a different perspective on the world’s treatment of COVID-19.
Reference40 articles.
1. Overview. World Health Organization; 2022 [cited 2022 11/18/2022]; Available from: https://covid19.who.int/
2. COVID-19 Treatments and Medications. Centers of disease control and prevention; 2022[cited 2022 10/19/2022]; Available from: https://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html#print
3. McMullan B.J., Mostaghim M.. Aust Prescr, 38 (2015), p. 87
4. Macrolides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains
5. Min JY, Jang YJ.. Mediators Inflamm, 2012 (2012), Article 649570)